Medidata Solutions Company Profile (NASDAQ:MDSO)

Analyst Ratings

Consensus Ratings for Medidata Solutions (NASDAQ:MDSO) (?)
Ratings Breakdown: 1 Sell Rating(s), 2 Hold Rating(s), 8 Buy Rating(s)
Consensus Rating:Buy (Score: 2.64)
Consensus Price Target: $51.78 (2.75% downside)

Analysts' Ratings History for Medidata Solutions (NASDAQ:MDSO)
Show:
DateFirmActionRatingPrice TargetActions
7/24/2016Needham & Company LLCReiterated RatingBuy$55.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2016Wells Fargo & Co.DowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/7/2016KeyCorpReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/10/2016Morgan StanleyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/25/2016Leerink SwannReiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/26/2016Jefferies GroupDowngradeHold -> Underperform$35.00 -> $36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/22/2016Citigroup Inc.Boost Price TargetBuy$40.00 -> $55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/22/2016Topeka Capital MarketsReiterated RatingBuy$44.00 -> $51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016Deutsche Bank AGLower Price TargetBuy$53.00 -> $41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/8/2015Piper Jaffray Cos.Reiterated RatingBuy$61.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/28/2015Stifel NicolausLower Price TargetBuy$65.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2015SunTrust Banks Inc.Boost Price TargetNeutral$45.00 -> $58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/29/2014JPMorgan Chase & Co.Reiterated RatingOverweight$60.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/29/2014Credit Suisse Group AGReiterated RatingOutperform$54.00 -> $49.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2014 forward)

Earnings

Earnings History for Medidata Solutions (NASDAQ:MDSO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
10/25/2016        
7/20/2016Q216$0.23$0.24$112.39 million$114.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/21/2016Q116$0.18$0.25$103.22 million$104.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2016Q415$0.24$0.27$105.09 million$98.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2015Q315$0.24$0.25$103.49 million$103.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/21/2015Q215$0.20$0.22$97.27 million$98.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/23/2015Q115$0.14$0.17$91.05 million$92.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/5/2015Q414$0.22$0.23$91.12 million$89.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2014Q314$0.22$0.20$87.72 million$86.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2014Q214$0.18$0.17$81.90 million$83.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/22/2014Q114$0.16$0.11$79.50 million$76.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/6/2014Q413$0.17$0.23$73.97 million$74.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2013Q313$0.33$0.40$70.74 million$70.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2013Q2 2013$0.12$0.20$66.71 million$68.07 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2013Q1 2013$0.23$0.35$61.32 million$63.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/21/2013Q4 2012$0.28$0.35$59.12 million$58.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/31/2012$0.31$0.29ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2012$0.23$0.23ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2012$0.22$0.26ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/6/2012$0.37$0.37ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/8/2011$0.34$0.42ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/9/2011$0.33$0.40ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/10/2011$0.23$0.21ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/15/2011$0.26$0.29ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Medidata Solutions (NASDAQ:MDSO)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20161$0.12$0.12$0.12
Q4 20161$0.14$0.14$0.14
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Medidata Solutions (NASDAQ:MDSO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Medidata Solutions (NASDAQ:MDSO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
7/22/2016Michael I. OtnerEVPSell7,500$51.27$384,525.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/20/2016Steven Isaac HirschfeldVice ChairmanSell20,825$52.89$1,101,434.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/12/2016Steven Isaac HirschfeldVice ChairmanSell10,000$49.85$498,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/12/2016Tarek SherifCEOSell22,036$49.24$1,085,052.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/12/2016Vries Glen Michael DePresidentSell32,500$49.25$1,600,625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/5/2016Tarek SherifCEOSell7,500$46.35$347,625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/29/2016Steven Isaac HirschfeldVice ChairmanSell10,000$45.66$456,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2016Vries Glen Michael DePresidentSell7,500$47.66$357,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2016Tarek SherifCEOSell7,500$45.90$344,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/31/2016Robert TaylorDirectorSell3,752$45.03$168,952.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/25/2016Neil M KurtzDirectorSell5,937$44.95$266,868.15View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/25/2016Steven Isaac HirschfeldVice ChairmanSell10,000$44.94$449,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/25/2016Tarek SherifCEOSell7,500$45.00$337,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/27/2016Steven Isaac HirschfeldVice ChairmanSell10,000$45.09$450,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/25/2016Eileen SchlossEVPSell68,717$46.53$3,197,402.01View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/25/2016Vries Glen Michael DePresidentSell7,500$46.36$347,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/16/2016Lee ShapiroDirectorBuy1,500$33.45$50,175.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/21/2015Steven Isaac HirschfeldInsiderSell5,293$61.00$322,873.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/20/2015Steven Isaac HirschfeldInsiderSell4,908$59.00$289,572.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2015Eileen SchlossEVPSell2,084$57.10$118,996.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2015Robert TaylorDirectorSell5,048$56.81$286,776.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2015Steven Isaac HirschfeldInsiderSell22,153$53.36$1,182,084.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2015Eileen SchlossEVPSell4,166$55.20$229,963.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/28/2015Cory DouglasCFOSell12,333$55.29$681,891.57View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/23/2015Vries Glen Michael DePresidentSell20,000$49.89$997,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2015Eileen SchlossEVPSell12,065$46.98$566,813.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2015Michael I OtnerEVPSell11,010$46.75$514,717.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2015Bryan Charles SpielmanEVPSell5,851$45.00$263,295.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2015Robert TaylorDirectorSell28,672$44.07$1,263,575.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2015Cory DouglasCFOSell38,000$44.24$1,681,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2015Eileen SchlossEVPSell12,499$44.43$555,330.57View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2014Steven Isaac HirschfeldInsiderSell22,075$42.53$938,849.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2014Michael L CaponeCOOBuy2,400$40.01$96,024.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/3/2014Tarek SherifCEOSell20,000$45.30$906,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2014Vries Glen Michael DePresidentSell20,000$48.51$970,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2014Bryan Charles SpielmanEVPSell20,000$47.73$954,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/22/2014Steven Isaac HirschfeldEVPSell23,801$44.00$1,047,244.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2014Michael I OtnerEVPSell10,000$44.84$448,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2014Tarek SherifCEOSell20,000$44.81$896,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/4/2014Bryan Charles SpielmanEVPSell2,261$45.00$101,745.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/8/2014Vries Glen Michael DePresidentSell20,000$40.13$802,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/7/2014Tarek SherifCEOSell20,000$43.20$864,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/17/2014Tarek SherifCEOSell19,818$40.27$798,070.86View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/17/2014Vries Glen Michael DePresidentSell20,000$40.26$805,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2014Vries Glen Michael DePresidentSell20,000$47.71$954,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/3/2014Tarek SherifCEOSell20,000$55.05$1,101,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2014Eileen SchlossEVPSell16,847$60.76$1,023,623.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014Steven Isaac HirschfeldEVPSell17,000$60.03$1,020,510.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2014Vries Glen Michael DePresidentSell20,000$54.40$1,088,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/14/2014Vries Glen Michael DePresidentSell20,000$59.35$1,187,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/6/2014Tarek SherifCEOSell20,000$59.44$1,188,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/13/2013Steven Isaac HirschfeldEVPSell10,000$113.01$1,130,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2013Steven Isaac HirschfeldEVPSell10,000$116.59$1,165,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2013Vries Glen Michael DePresidentSell10,000$116.39$1,163,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/6/2013Tarek SherifCEOSell53,290$118.08$6,292,483.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/6/2013Vries Glen Michael DePresidentSell43,289$118.11$5,112,863.79View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2013Cory DouglasCFOSell10,000$108.08$1,080,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/1/2013Cory DouglasCFOSell30,000$109.59$3,287,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2013Eileen SchlossEVPSell12,500$116.08$1,451,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2013Lee ShapiroDirectorSell3,800$117.48$446,424.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2013Michael I OtnerEVPSell5,071$117.45$595,588.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2013Bryan Charles SpielmanEVPSell3,905$99.47$388,430.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2013Michael I OtnerEVPSell2,500$92.16$230,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/26/2013Vries Glen Michael DePresidentSell56,547$90.08$5,093,753.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2013Bryan Charles SpielmanEVPSell4,145$86.66$359,205.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2013Bryan Charles SpielmanEVPSell3,950$78.78$311,181.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/28/2013Steven Isaac HirschfeldEVPSell5,486$76.84$421,544.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2013Steven Isaac HirschfeldEVPSell5,189$68.84$357,210.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2013Steven Isaac HirschfeldEVPSell10,711$67.60$724,063.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2013Robert TaylorDirectorSell4,533$70.31$318,715.23View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2013Neil M KurtzDirectorSell5,910$66.02$390,178.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2013Lineene Norris KrasnowEVPSell18,690$50.39$941,789.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/22/2013Vries Glen Michael DePresidentSell56,547$50.20$2,838,659.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/4/2012Tarek SherifCEOSell40,000$39.47$1,578,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/3/2012Vries Glen Michael DePresidentSell27,604$39.77$1,097,811.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Medidata Solutions (NASDAQ:MDSO)
DateHeadline
07/28/16 07:48 AMNew Cancer-Focused Biotech Forty Seven Inc. Selects Medidata to Accelerate Novel Immuno-Oncology R&D - [at noodls] - Stanford University Startup Leverages Medidata's Cloud Technology to Tackle Cancers with Limited Treatment Options NEW YORK--(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based ...
07/22/16 07:48 AMMedidata Cloud Technology Selected to Support Biogen Clinical Trials - [at noodls] - NEW YORK--(BUSINESS WIRE)-- Medidata (NASDAQ: MDSO) today announced that its cloud technology has been selected by Biogen to support future clinical trials. Biogen will increase its adoption of Medidata ...
07/22/16 07:30 AM8:30 am Medidata Solutions announces its cloud technology has been selected by Biogen (BIIB) to support future clinical trials -
07/21/16 02:47 PMMedidata (MDSO) Tops Q2 Earnings & Revenues, Shares Up -
07/21/16 01:14 PMETF’s with exposure to Medidata Solutions, Inc. : July 21, 2016 -
07/21/16 11:06 AMMedidata Solutions, Inc. :MDSO-US: Earnings Analysis: Q2, 2016 By the Numbers : July 21, 2016 -
07/21/16 05:59 AMMedidata Solutions downgraded by Wells Fargo -
07/20/16 05:49 PMForm 8-K Medidata Solutions, Inc. For: Jul 20
07/20/16 05:49 PMMid-Morning Market Update: Markets Open Higher; Morgan Stanley Beats Q2 Estimates
07/20/16 05:49 PMMedidata Solutions : tops Street 2Q forecasts
07/20/16 05:49 PMMedidata Solutions (MDSO) Tarek A. Sherif on Q2 2016 Results - Earnings Call Transcript
07/20/16 01:49 PMEdited Transcript of MDSO earnings conference call or presentation 20-Jul-16 12:00pm GMT -
07/20/16 11:42 AMMedidata Solutions +10% on EPS, revenue beat -
07/20/16 06:07 AMQ2 2016 Medidata Solutions Inc Earnings Release - Before Market Open -
07/20/16 05:39 AMMedidata tops Street 2Q forecasts - [AP] - On a per-share basis, the New York-based company said it had profit of 9 cents. Earnings, adjusted for one-time gains and costs, came to 24 cents per share. The results exceeded Wall Street expectations. ...
07/19/16 04:30 PMMedidata Collaborates with Leading New York Cancer Center to Expand the Use of mHealth Technology in Oncology Care - [Business Wire] - Medidata , the leading global provider of cloud-based solutions for clinical research in life sciences, today announced it is collaborating with Memorial Sloan Kettering Cancer Center to expand the use of mobile health technology in oncology treatment.
07/19/16 08:25 AMMedical Product Earnings on Jul 20: STJ, MDSO, BABY -
07/18/16 10:25 AMMedidata : Introduces New Payment Technology on its Unified Platform to Automate Reimbursements to Clinical Trial Sites
07/18/16 07:30 AMMedidata Introduces New Payment Technology on its Unified Platform to Automate Reimbursements to Clinical Trial Sites - [Business Wire] - Medidata , the leading global provider of cloud-based solutions for clinical research in life sciences, today announced the launch of Medidata Payments. A new component of the industry-leading Medidata Clinical Cloud®, Medidata Payments enables clinical trial sponsors and contract research organizations to calculate reimbursements to investigative sites in real time and automatically disburse payments, ...
07/06/16 01:35 PMETF’s with exposure to Medidata Solutions, Inc. : July 6, 2016 -
07/06/16 07:51 AMMedidata Schedules Second Quarter Earnings Conference Call for July 20, 2016 - [at noodls] - NEW YORK--(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it will release its second quarter ...
07/05/16 04:41 PMHanmi Selects Medidata to Power Drug Development with Cloud Technology - [at noodls] - Korea's Top Pharma Adopts Medidata's Platform to Optimize All Clinical Trials Across Therapeutic Areas NEW YORK--(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions ...
06/30/16 07:39 AMWhy You Shouldn't Bet Against Medidata Solutions (MDSO) Stock -
06/29/16 07:58 AMMedidata : Named Among 100 Best Workplaces for Millennials
06/29/16 07:51 AMMedidata Named Among 100 Best Workplaces for Millennials - [at noodls] - Inspiring Mission, Collaborative Company Culture and Work-Life Flexibility Earn Medidata a Spot on Fortune's Annual List NEW YORK--(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider ...
06/28/16 08:10 AMMedidata Solutions, Inc. breached its 50 day moving average in a Bearish Manner : MDSO-US : June 28, 2016 -
06/27/16 11:46 AMMedidata Solutions, Inc. :MDSO-US: Earnings Analysis: Q1, 2016 By the Numbers : June 27, 2016 -
06/21/16 02:00 AMUniversity of Southampton Leverages Medidata Clinical Cloud to Bridge Innovation Gap Between Academia and UK Drug Development Industry -
06/20/16 08:46 AMMoving Average Crossover Alert: Medidata (MDSO) -
06/14/16 09:53 AMMedidata Solutions : Leading Korean CRO Strengthens Global R&D Capabilities by Expanding Use of Medidata's Cloud Technology Platform
06/13/16 04:49 PMLeading Korean CRO Strengthens Global R&D Capabilities by Expanding Use of Medidata's Cloud Technology Platform - [at noodls] - LSK Global PS Adopts Medidata's Clinical Trial Management Solution for Worldwide Operational Efficiency and Project Oversight NEW YORK & SEOUL, Korea--(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading ...
06/13/16 04:31 PMLeading Korean CRO Strengthens Global R&D Capabilities by Expanding Use of Medidata’s Cloud Technology Platform - [Business Wire] - NEW YORK & SEOUL, Korea--(BUSINESSWIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, and LSK Global Pharma Services (“LSK Global ...
06/07/16 03:59 PMMEDIDATA SOLUTIONS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submiss -
06/07/16 07:42 AMWhy Medidata Solutions (MDSO) Could Be an Impressive Growth Stock -
06/06/16 07:59 AMCan Medidata Solutions (MDSO) Keep the Earnings Streak Alive This Quarter? -
06/02/16 05:28 PMOmnicell Grows amid Weak Margins, Hospital Spending Woes - Inc. ATHN and Medidata Solutions, Inc. MDSO. All the three stocks hold a Zacks Rank #2 (Buy). Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
05/30/16 10:26 AMNext Weeks Broker Price Targets For Medidata Solutions, Inc. (NASDAQ:MDSO) - Share Trading News - Next Weeks Broker Price Targets For Medidata Solutions, Inc. (NASDAQ:MDSO)Share Trading News04/26/2016 – Leerink Swann began new coverage on Medidata Solutions, Inc. giving the company a “market perform” rating. They now have a USD 47 price target on the stock. 04/22/2016 – Medidata Solutions, Inc. had its “buy” rating reiterated by analysts ...Medidata Solutions Incorporated (NASDAQ:MDSO) Short Interest Increased By 10.78%The PostMedidata Solutions, Inc. (NASDAQ:MDSO) Costs Of Goods Sold Stands At $89.788 MillionsEnterprise Leaderall 3 news articles »
05/27/16 07:04 PMStock Rating Review for Medidata Solutions, Inc. (NASDAQ:MDSO) - Wall Street Hints and News - Stock Rating Review for Medidata Solutions, Inc. (NASDAQ:MDSO)Wall Street Hints and NewsCovering equity analysts presently have a consensus stock rating of 1.77 on shares of Medidata Solutions, Inc. (NASDAQ:MDSO). Covering analysts will often provide Sell, Hold, or Buy recommendations based on their advanced research. This consensus ...and more »
05/27/16 07:47 AMMedidata Invites Investors and Analysts to Join Webcast on June 2, 2016 - [at noodls] - Webcast to Feature Highlights from Recent Medidata Symposium in Barcelona, Spain, Followed by Live Q&A with Management NEW YORK--(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of ...
05/26/16 06:54 AMTrading Overview of Two Stocks: Tower Semiconductor Ltd. (NASDAQ:TSEM) , Medidata Solutions, Inc. (NASDAQ ... - Street Updates - Trading Overview of Two Stocks: Tower Semiconductor Ltd. (NASDAQ:TSEM) , Medidata Solutions, Inc. (NASDAQ ...Street UpdatesMedidata Solutions, Inc. (NASDAQ:MDSO) moved in green zone with rise of +0.22 points or +0.49% to $44.84. The company has a market worth of $2.48B.Total 371.47 thousand shares were exchanged in last trading session as opposed to average volume ...
05/23/16 11:58 PMStock Paining Investors: Medidata Solutions, Inc. (NASDAQ:MDSO) - Wall Street Hints and News - Stock Paining Investors: Medidata Solutions, Inc. (NASDAQ:MDSO)Wall Street Hints and NewsMedidata Solutions, Inc. (NASDAQ:MDSO) shares have underperformed for investors this year as the stock has dropped -21.53% for the year. Shareholders are shaking their heads and questioning their investment and pondering what their next move will be.and more »
05/20/16 11:54 PMAnalyst Rating Check on Medidata Solutions, Inc. (NASDAQ:MDSO) - Wall Street Hints and News - Analyst Rating Check on Medidata Solutions, Inc. (NASDAQ:MDSO)Wall Street Hints and NewsCurrently, sell-side analysts have provided a consensus stock rating of 1.77 on shares of Medidata Solutions, Inc. (NASDAQ:MDSO). Analysts that cover the company will usually offer Buy, Sell, or Hold recommendations based on in-depth research.and more »
05/20/16 11:54 PMLatest Analyst Ratings For Medidata Solutions, Inc. (NASDAQ:MDSO) - Share Trading News - NasdaqLatest Analyst Ratings For Medidata Solutions, Inc. (NASDAQ:MDSO)Share Trading News04/26/2016 – Leerink Swann began new coverage on Medidata Solutions, Inc. giving the company a “market perform” rating. They now have a USD 47 price target on the stock. 04/22/2016 – Medidata Solutions, Inc. had its “buy” rating reiterated by analysts ...Medidata Solutions Incorporated (NASDAQ:MDSO) Shorted Shares Increased 3.05% After Market SellingWall Street Hints and NewsCommit To Buy Medidata Solutions At $35, Earn 10.2% Annualized Using OptionsNasdaqall 3 news articles »
05/20/16 06:46 PMCommit To Buy Medidata Solutions At $35, Earn 10.2% Annualized Using Options - Investors eyeing a purchase of Medidata Solutions, Inc. (Symbol: MDSO) shares, but tentative about paying the going market price of $42.91/share, might benefit from considering selling puts among the alternative strategies at their disposal. One ...
05/20/16 12:00 AMShare Performance and Target Price Review for Medidata Solutions, Inc. (NASDAQ:MDSO) - Wall Street Hints and News - Share Performance and Target Price Review for Medidata Solutions, Inc. (NASDAQ:MDSO)Wall Street Hints and NewsLooking at stock activity from multiple angles may be of benefit when examining share performance. Investors have the ability to focus in on short or long term share performance. During the most recent trading session, Medidata Solutions, Inc.and more »
05/18/16 06:49 PMWere Analysts Bearish Medidata Solutions Inc (NASDAQ:MDSO) This Week? - Wall Street Hints and News - Were Analysts Bearish Medidata Solutions Inc (NASDAQ:MDSO) This Week?Wall Street Hints and NewsOut of 11 analysts covering Medidata Solutions Inc. (NASDAQ:MDSO), 9 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 82% are positive. Medidata Solutions Inc. has been the topic of 12 analyst reports since July 22, 2015 according to ...and more »
05/18/16 12:04 PMMEDIDATA SOLUTIONS, INC. Financials -
05/17/16 10:58 AMMDSO Makes Bullish Cross Above Critical Moving Average - In trading on Tuesday, shares of Medidata Solutions, Inc. (Symbol: MDSO) crossed above their 200 day moving average of $43.24, changing hands as high as $43.52 per share. Medidata Solutions, Inc. shares are currently trading up about 0.1% on the day.
05/16/16 06:31 PMAfter Last Week What Do Analysts Think Of Medidata Solutions, Inc. (NASDAQ:MDSO) - Share Trading News - After Last Week What Do Analysts Think Of Medidata Solutions, Inc. (NASDAQ:MDSO)Share Trading News04/26/2016 – Leerink Swann began new coverage on Medidata Solutions, Inc. giving the company a “market perform” rating. They now have a USD 47 price target on the stock. 04/22/2016 – Medidata Solutions, Inc. had its “buy” rating reiterated by analysts ...and more »
05/14/16 12:15 AMConsensus Rating Review for Medidata Solutions, Inc. (NASDAQ:MDSO) - Wall Street Hints and News - Consensus Rating Review for Medidata Solutions, Inc. (NASDAQ:MDSO)Wall Street Hints and NewsEquity research analysts currently have a consensus rating of 1.77 on shares of Medidata Solutions, Inc. (NASDAQ:MDSO). Sell-side analysts will typically rate a company's stock based on extensive research. These ratings usually translate into a Buy ...and more »

Social

About Medidata Solutions

Medidata Solutions logoMedidata Solutions Inc. (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Medidata Clinical Cloud provides a platform of technology and data analytics solutions designed to manage activities across clinical development. Its Planning Cloud provides capabilities for study design and planning, enabling customers to make use of resources through planning at the start of trial design and protocol development. Specific functionality supports visibility into the impact of protocol elements on resource and trial endpoints; comparisons to specific industry benchmarks, and analytics to support appropriate grants to investigator sites and automated negotiations with multiple investigator sites. Data Capture Cloud is Medidata's electronic data capture (EDC) and its management system solution is Medidata Rave.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Healthcare Information Services
  • Sub-Industry: Health Care Technology
  • Exchange: NASDAQ
  • Symbol: MDSO
  • CUSIP: 58471A10
Key Metrics:
  • Previous Close: $53.24
  • 50 Day Moving Average: $47.56
  • 200 Day Moving Average: $42.10
  • P/E Ratio: 136.86
  • P/E Growth: 2.72
  • Market Cap: $2.95B
  • Beta: 1.38
  • Current Year EPS Consensus Estimate: $1.01 EPS
  • Next Year EPS Consensus Estimate: $1.24 EPS
Additional Links:
Medidata Solutions (NASDAQ:MDSO) Chart for Thursday, July, 28, 2016